In a mouse collagen induced arthritis model, apoptotic cell therapy delayed the clinical onset and protected mice from severe joint inflammation and bone destruction through this mechanism where inhibition of IL-10 in vivo reversed the beneficial effects of apoptotic cells. This evidence concerns the gene IL10 and arthritic joint disease.